Biond Biologics Competitors and Similar CompaniesClear all
Biond Biologics's competitors and similar companies include Keros Therapeutics, Veloxis Pharmaceuticals, Evox Therapeutics and Apic Bio.
 Biond Biologics Biond Biologics is a company developing immunotherapies for cancer and autoimmune diseases. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. |  Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies. |  Apic Bio Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases. | |
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2002 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Nahariya, IL HQ | Locations Lexington, US HQ South Wharf, AU | Locations København, DK HQ Cary, US Cary, US | Locations Oxford, GB HQ | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 40 | Employees 7854% decrease | Employees 54 | Employees 452% decrease | Employees 6 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $244.1m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income $87m (FY, 2025) | Net income (kr5.3m) (FY, 2018) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 17m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 40m (over 7 years ago) |
Total funding raised | Total funding raised $ 17m | Total funding raised $ 90m | Total funding raised $ 60m | Total funding raised $ 158.6m | Total funding raised $ 51m |
For sources of this data, please see the company profile
View Company Profiles
Keros Therapeutics
HQ
Lexington, US
Employees
78
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View companyVeloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View companyEvox Therapeutics
HQ
Oxford, GB
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.
View companyApic Bio
HQ
Cambridge, US
Employees
6
Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases.
View company